arGentis Pharmaceuticals, LLC
http://www.argentisrx.com/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From arGentis Pharmaceuticals, LLC
arGentis acquires rights to rheumatoid arthritis therapy
The privately held biopharmaceutical company arGentis Pharmaceuticals is to collaborate with the University of Tennessee Health Science Center (UTHSC) and the Veterans Affairs Medical Center (VAMC) of Memphis to progress the oral altered peptide ligand (APL), ARG301, into a Phase I study in rheumatoid arthritis patients.
Company Information
- Industry
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
arGentis Pharmaceuticals, LLC
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice